250 Parkway Drive
Tel: 847 243-1200
3 articles with NantPharma
Los Angeles Court Rejects Patrick Soon-Shiong’s Attempt to Avoid Sorrento Litigation Allowing Arbitration Case to Move Forward
Sorrento Therapeutics, Inc. announced today that a Los Angeles Superior Court judge has rejected Patrick Soon-Shiong’s attempt to allow him and his company, NantPharma, to avoid the billion-dollar fraud and breach of contract claims that Sorrento filed against them earlier this year.
4/4/2019The lawsuit alleges that Soon-Shiong acquired the promising cancer treatment in order to prevent it from coming to market and challenging revenues from Celgene's Abraxane, a drug Soon-Shiong developed.